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Abstract 
The purpose of this study is to develop the application of Signal Amplification By 
Reversible Exchange (SABRE) hyperpolarisation to New Psychoactive Substance (NPS) 
analysis. Piperazine derivatives are the compounds under investigation due to their 
strong prevalence in the last ten years as a New Psychoactive Substances (NPS) which 
posed/poses a threat to the general public, particularly the younger generation. Firstly, 
this study aimed to fully characterise 1-[(2-pyridyl)methyl]piperazine, 1-[(3-
pyridyl)methyl]piperazine and 1-[(4-pyridyl)methyl]piperazine (2, 3 and 4-PMP 
respectively). Secondly, it was important to develop a quantitative method for detection 
of these compounds using bench top 1H Nuclear Magnetic Resonance (NMR). Standard 
addition (SA) and Internal Standard (IS) calibrations were the methods investigated for 
their suitability. The largest part of the project was to explore the feasibility to 
hyperpolarise the compounds under investigation due to the presence of a pyridyl 
functionality. Hyperpolarisation can lower detection limits, cut costs and offer quicker 
and better results than conventional NMR. SABRE was the hyperpolarisation method 
employed due to its ease, low cost and impressive literature results. The final aim was 
to develop/optimise and apply a method to extract and detect the NPS from a common 
formulation. It was discovered that 3 equivalents of triethylamine was the optimum 
amount to freebase 4-PMP.3HCl. The method of standard addition using bench-top 
NMR was incredibly accurate in determining the concentration of PMP samples with 
unknown concentrations. Finally, a mixture of all three isomers was distinguishable 
through the use of GC-MS. In addition to this, it was also possible to extract the drug 
from a common formulation (tablet) in its un-hyperpolarisable state, freebase it and 
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then successfully hyperpolarise. This thesis provides an acceptable application of SABRE 
to the analysis of NPS. 
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1. Introduction 
1.1. New Psychoactive Substances (NPS) 
Over the years the terms research drugs, legal highs, designer drugs and NPS have 
become increasingly familiar, which is no doubt a result of their growing popularity. NPS 
are described as “narcotic or psychotropic drugs that are not scheduled under the 
United Nations 1961 or 1971 Conventions, but which may pose a threat to public health 
comparable to scheduled substances”.1 They are synthetically made substances, often 
produced by underground chemists in China and India, that are designed to mimic the 
behaviour of popular illicit drugs such as cocaine, 3,4-
methylenedioxymethamphetamine (MDMA) and cannabis.2  
 
1.1.1. Prevalence of NPS  
What are now known as NPS established a solid presence on society in the United States 
in 1984, when a number of fentanyl derivatives made their way on to the illicit drug 
market. Despite its imprecision, the name ‘designer drugs’ was coined in respect to the 
lab made opioids.1, 3 Interest in the substances faded, however, when a synthetic 
impurity (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) (MPTP) found in a prodine 
derivative led to users chemically inducing themselves with Parkinson’s disease.1 A 
number of phenethylamine based drugs made attempts at finding a long-lasting place 
on the market with little success. Gamma-hydroxybutyrate (GHB), a ‘failed 
pharmaceutical’, was at first believed to aid muscle development and so found a niche 
market within the bodybuilding community. Although it was not incredibly popular, it  
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did not take long for recreational drug users to discover its potential to offer experiences 
of euphoria or sedation.1, 4 NPS prominence was re-established, despite being short-
lived, lasting in to the early 2000’s after the production of hallucinogenic analogues 
made their way on to the scene. Benzylpiperazine (BZP), a piperazine derivative, is 
arguably the first NPS to maintain a solid hold on the drug market. Legally marketed in 
New Zealand form the start of the 21st century as a safer alternative to 3,4-
methylenedioxy-methamphetamine (MDMA), millions of BZP pills were sold before the 
drug was detected in Europe.1, 5 A curious bit of research emerged when it became 
apparent that BZP had transitioned from being sold as a pill to being sold as a powder. 
The compelling fact here is that production had shifted from underground laboratories 
to established chemical companies, notoriously situated in Asia.1 The next phase in the 
emergence of NPS is based around synthetic cathinones and synthetic cannabinoids, 
such as mephedrone and Spice respectively. The start of this phase is subjective in the 
literature, with evidence to suggest cathinones properly surfaced substantially later 
than in the Soviet Union in the 70’s and 80’s or Germany in 1997. The use of Google 
Insights showed that there were almost no searches for synthetic cathinones before 
2008.6 However, this could be dismissed by looking at internet access data. The early 
2000’s saw the rise of the internet no doubt, but knowledge of using it to research drugs 
at that time remains an unanswered question. More recently, synthetic cannabinoids 
have caught the attention of researchers and the public. Prior to the passing of the 
Psychoactive Substances Act 2016 (PSA 2016), synthetic cannabinoids such as Spice 
were marketed legally as incense or room oderizers. Despite being labelled ‘not for 
human consumption’, synthetic cannabinoids were regularly purchased as a legal 
alternative to cannabis.7 Commonly the synthetic cannabinoid is sprayed onto plant 
material, which does not offer any psychoactive effects itself. In addition to this, they 
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can be purchased as a liquid or in the form of pills. With over 240 different synthetic 
cannabinoids reported to UNODC between 2008 and 2016, they form the largest NPS 
group. This is due to the fact there are an overwhelming amount of different structures 
reported. Additionally, twenty-nine fatalities throughout 2014 and 2015 directly linked 
to synthetic cannabinoids shows how much of a risk they pose to public health.8, 9  
 
1.1.2. Prevalence of Piperazines 
The start of the 21st century saw the growing popularity of MDMA and amphetamines 
alike, which influenced an influx of similarly structured compounds known as 
piperazines.10, 11 BZP became the most popular MDMA/amphetamine substitute, with 
most of its distribution found in New Zealand (under the name BZP party pills), however 
BZP was also detected in the U.K, Brazil and Japan.5, 12 Astonishingly, after many failed 
attempts by clandestine laboratories to make designer drugs fashionable, BZP broke the 
mould and stamped its mark on the world. Their attractive euphoric effects saw them 
become prominent on the club scene as a safer alternative to MDMA, with an estimated 
8 million servings sold between 2000 and 2005 in New Zealand.1, 5, 13 To put this into 
perspective, this is the same as 40% of New Zealand’s population purchasing one BZP 
pill per year in the 5-year period (2000–2005). To further confirm BZP’s use in the club 
scene, data collected in a report on BZP party pills conducted in New Zealand in 2006, 
reported that the most common age group to confirm use of the substance was 20-24 
year olds (48.8% of respondents). In addition to this, the report not only clarified that 
15-18 years of age were the most common reported ages of first use, it also stated that 
75.7% of respondents describe getting hold of BZP as ‘very easy’. This highlights the 
importance of the PSA 2016 in the UK.14, 15 Interestingly, a UK study in 2010 claimed 
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piperazines were the most common drugs in tablets bought over the internet, however, 
there is no data post-PSA 2016 unfortunately.12 Considering this comes years after the 
reign of BZP throughout New Zealand, it is intriguing to see that piperazines were still 
rife. The population of the UK is magnitudes larger than New Zealand and thus an influx 
of BZP of some kind, despite being safe guarded by the PSA, would prove tough to 
manage, particularly due to the demographic showing peak popularity amongst young 
people.15 Abuse and dependence potential is evident and has been confirmed by 
research, even though there are no clinical studies to support this, with 2.2% of 
respondents classifying themselves as dependant on BZP in New Zealand.15, 16 
Furthermore, like other illicit drugs, the risk of overdose is still present. In 2004 alone, 
21 people were reported to have overdosed due to BZP consumption (five solely due to 
BZP).5 In light of this, a study by Butler and Sheridan concluded by reporting that despite 
reports of young people suffering dangerous side effects as a result of BZP consumption, 
there was no evidence to back them up.17 The literature does, however, make a point of 
highlighting the potential need for harm reduction interventions in cases of risky use.17 
 
1.1.3. Research Importance 
The introduction of the 2016 Psychoactive Substances Act in the UK forced the 
distribution of the substance out of the hands of ‘head shops’ and retailers, and into the 
hands of drug dealers who work under no regulations. The amount of NPS substances 
reported is increasing year on year, thus, it is imperative to progress research in order 
to stay on top of the situation.8 Developing a wider range of detection and 
characterisation techniques is of benefit to reduce the risk posed to public health and 
safety by these substances. Literature states that there is a possibility of alternatives to 
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BZP surfacing to replace the drug in the future, adding another dynamic to the 
importance of research into potential future variants of these drugs.18 This study aims 
to characterise the NPS 4-PMP and its regioisomers before exploring the feasibility of 
their hyperpolarisation. Further to this, the development of a viable quantitation 
method using bench-top NMR will take place. Finally, a method will be developed to 
extract, detect and hyperpolarise the NPS from a common formulation. 
 
1.2. 1H Nuclear Magnetic Resonance (NMR) Spectroscopy 
The phenomenon that is NMR was first successfully detected in December 1945 by two 
separate groups of physicists in the United States. When Edward M. Purcell et al. at 
Harvard University and Felix Bloch et al. at Stanford University in California succeeded 
in detecting the first lucrative observation of NMR in solids and liquids, they set in 
motion the development of a new branch of science.19, 20 Their discovery was recognized 
worldwide and they were awarded the Nobel Prize in Physics in 1952.21 Today NMR 
spectroscopy is one of the most powerful and versatile analytical techniques available 
to scientists and is most commonly used in structure elucidation. NMR utilises the 
quantum mechanics of subatomic particles (protons, neutrons and electrons) due to 
their spin properties. In atoms such as 12C, 16O, 32S these spins are paired and therefore 
cancel each other out producing zero overall spin. However, there are a scope of atoms 
(1H, 13C, 31P, 15N, 19F etc.) whose nuclei do possess an overall spin allowing for analysis 
through NMR. Determining the spin of a given nucleus is relatively simple and can be 
done so by following the subsequent rules. If both the number of protons and neutrons 
are even, the nucleus will possess zero spin. When added together, if the number of 
protons plus the number of neutrons is odd, the nucleus will possess a half-integer spin 
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(1/2, 3/2, 5/2). If both the number of protons and neutrons are odd, the nucleus has a 
full integer spin (1, 2, 3).22 
 
1.2.1. Magnetic Field Alignment 
For 1H, upon the application of a magnetic field there are two possible alignments, 
orientation either with the magnetic field (alpha = α) or against it (beta = β). α is 
preferred due to its lower energy; however, the energy difference between both 
alignments is so small that natural population of both can be expected at room 
temperature. During the acquisition of an NMR spectrum, energy from a radio-
frequency (RF) coil is applied to the system, promoting a transition of α orientated nuclei 
to β nuclei. When the RF coil is turned off, relaxation of the nuclei begins (transitions 
from β back to α until thermal equilibrium reached), generating resonances which are 
recorded and displayed in a spectrum following Fourier transformation.23 
 
1.2.2. Chemical Shift 
Since the magnetic moment of specific nuclei, such as 1H, remains constant indefinitely, 
it could be presumed that 1H would give resonance signals at the same field/frequency 
values every time. To a scientist’s advantage this does not hold true and so chemical 
shift enables us to identify and characterise structures. Chemical shifts are the signature 
appearance of signals on an NMR spectrum derived from functional groups. These are a 
result of electrons in the surrounding environment of the proton responding to the 
external magnetic field they are subjected to, and so different 1H environments produce 
different chemical shifts. Electrons generate a conflicting field to the much stronger, 
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external magnetic field. The conflicting field acts as a shield to the nucleus (Zeeman 
interactions (Hz)) from the external magnetic field. These interactions are amended by 
the chemical shielding effect described by the shielding constant, and the indirect spin-
spin coupling contribution (Hj), which outlines the connection between two 
neighbouring nuclei.24, 25 It is for this reason, to overcome shielding effects, that NMR 
spectrometers typically employ magnets between 1 and 20 Tesla (T).26 It is understood 
that nuclei with more shielding will have a lower ppm (parts per million) and will be 
situated in the aliphatic region of the spectrum (right side), whilst nuclei with less 
shielding will have a higher ppm and will be situated in the aromatic region (left side). 
 
1.3. Hyperpolarisation 
One of NMR’s greatest disadvantages is its inherent low sensitivity, which arises from 
the very small population differences that exist between nuclear spin states. 
Hyperpolarisation, which is comprised of a variety of techniques, has proven successful 
in improving the sensitivity of NMR spectroscopy whilst also providing the fundamental 
building blocks for advancement in drug detection, characterisation and quantification, 
as well as Magnetic Resonance Imaging (MRI).27 Each of the six techniques; Brute force, 
Dynamic Nuclear Polarisation (DNP), Spin Exchange Optical Pumping (SEOP), Para-
hydrogen and synthesis allow dramatic enhanced nuclear alignment (PASADENA), 
Adiabatic longitudinal transport after dissociation engenders net alignment (ALTADENA) 
and Signal Enhancement By Reversible Exchange (SABRE), achieve enhanced 
polarisation in a different way. Where some are invasive and chemically change the 
substrate, others are not and propagate magnetisation in other ways. Essentially, non-
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Boltzmann distributions are the desired outcome, of which some methods to achieve 
this are discussed below. 
 
1.3.1. Brute-Force 
Often referred to as the simplest HP method, Brute-Force enhances NMR signals by 
simply altering the conditions of the environment a sample is polarised in. Two factors 
crucial to NMR are altered: Temperature (K) and magnetic field (B). By polarising a 
sample in a high-field – low temperature environment (lowering T to <4 K and increasing 
B to 14 T), Brute-Force polarisation can take place. Lowering T prevents population of 
the thermal equilibrium energy level whilst increasing B helps to provide energy to 
promote α orientated spins to β orientated spins. The main advantage of Brute-Force is 
the simplicity of the method; there is no requirement to chemically alter the target 
compound, thus HP acquisition is quicker as it relies solely on Boltzmann-law 
polarisation rather than secondary chemistry or physics. A further advantage is the un-
necessity for free radicals, microwave excitation or co-solvents that are essential in 
DNP.28, 29 It is worth noting that detection is carried out at a much lower magnetic field, 
commonly below 40 mT.30 
 
1.3.2. Dynamic Nuclear Polarisation (DNP) 
Expanding hyperpolarisation in its most simple form is the promising technique, DNP.29 
Moving away from harnessing the power of low temperatures and high magnetic fields, 
DNP provides hyperpolarisation through the application of microwave excitation to 
electron spins.31 Polarisation is transferred to neighbouring nuclei contained in a glass-
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forming matrix at cryogenic temperatures (100 K ≥).32, 33 In comparison to Brute-force, 
the increase in temperature offered by DNP is an advantage in terms of experimental 
difficulty, while impressive signal enhancements (80-fold <) have provided momentum 
to the method, probing the development of an ever increasing range of systems.33 
Interestingly, lower enhancements can reduce experiment times  massively as the 
amount of time required for signal averaging is inversely proportional to the square of 
the enhancement.34 With this being said DNP does come with its fair share of limitations. 
Firstly, when T1 (relaxation time) times are short, the detection of nuclei becomes 
difficult or impossible. This causes identification of unknown compounds to be 
challenging requiring the need for extra analysis by conventional NMR spectroscopy. 
Secondly, the pre-condition of radical insertion to the sample (electron source) is often 
an un-desirable action to scientists, especially after time consuming isolation and 
purification methods have been used to isolate and/or purify a product.35 The 
application of DNP to 13C can increase sensitivity by many orders of magnitude, thus, 
providing a solution to the low gyromagnetic ratio of 13C in regard to NMR, making it 
applicable to MRI.36  
 
1.3.3. Spin-Exchange Optical Pumping (SEOP) 
The development of SEOP has advanced the resolution of MRI by providing a niche 
pathway for the HP of 3He and 129Xe.37 It works by utilising circularly polarised light to 
excite alkali-metal atoms, which in turn collide with a larger quantity of noble-gas atoms 
(3He and 129Xe). The excitation transfers close to 50% of the spin angular momentum to 
the alkali-metal atoms, causing subsequent collisions with noble-gas atoms to transfer 
some of the electron-spin polarization to noble-gas nuclei.38 Primarily, hyperpolarised 
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noble gasses such as helium and xenon offer an improvement to current methods of 
determining the health and condition of lung space. Inhaled hyperpolarised noble 
gasses, used as ‘imaging agents’, offer clearer, more resolute images as a result. The 
technique isn’t massively time consuming (producing 0.3 L of 64% polarised 129Xe per 
hour) but isn’t remarkably fast at the same time.39 Compared to DNP, SEOP is generally 
favoured as a producer of MRI agents because of its focus on gasses, despite its 
limitation to noble gasses. However, in terms of speed, Para-Hydrogen Induced 
Polarisation (PHIP) techniques perform better and can achieve enhancements far 
greater than what has been seen with Brute-force, DNP and SEOP. 
 
1.3.4. Para-Hydrogen Induced Polarisation (PHIP)  
A very effective approach to altering the Boltzmann distribution is PHIP. This technique 
provides polarisation through the use of a spin isomer of hydrogen, para-Hydrogen (p-
H2). p-H2 contains a pair of protons that form a singlet spin state which has no magnetic 
moment and thus does not give rise to a signal when probed via NMR.30 Following a 
prediction in 1986 that PHIP could be used to increase NMR signal intensities, Bowers 
and Weitekamp successfully proved the concept by achieving enhancement factors 
between 100 and 200 on several samples.40 PHIP itself has three different approaches; 
PASADENA, ALTADENA and SABRE.30, 41, 42 Whereas DNP and SEOP are generally 
considered for use in MRI, PHIP methods are more suited towards chemical analysis, 
characterisation, and to provide insight into the species involved in reaction 
mechanisms.43 
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1.3.5. PASADENA (Para-hydrogen and synthesis allow dramatic enhanced nuclear 
alignment) 
p-H2 hydrogenates an unsaturated substrate in a high magnetic field with the p-H2 nuclei 
consequently taking up magnetically inequivalent sites in said substrate, before 
polarisation is detected using radio-frequency pulses. Polarisation is relayed dominantly 
through the resulting (dynamic) dipolar coupling network.44 This method is mostly used 
to study homogeneously catalysed hydrogenation reactions, not just for the detection 
of low concentration intermediates, but also to evaluate reaction mechanism and the 
kinetics involved. Characterised by its use of both high and low-field magnets, 
PASADENA is often employed over alternative PHIP methods due to its ease and 
reproducibility of handling, spectra quality and potential applications for in situ 
studies.45 Despite its reputation among scientists as one of the most effective 
hyperpolarisation methods, it is however intrusive. The substrate is chemically different 
following the addition of p-H2, therefore reducing its applicability in work such as drug 
detection, characterisation and discovery.  
 
1.3.6. ALTADENA (Adiabatic longitudinal transport after dissociation engenders 
net alignment) 
The sibling of PASADENA, ALTADENA offers a slightly different approach towards PHIP. 
The requirement of an unsaturated substrate remains, as hydrogenation with p-H2 of a 
double/triple bond is fundamental. As it states in the name, ALTADENA conditions 
involve adiabatic transfer.44, 46 Instead of polarisation taking place at high-field prior to 
detection at low-field, ALTADENA does the exact opposite and adopts a concept known 
as ‘isotropic mixing’. Samples are polarised in the stray field of the NMR magnet before 
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detection in the high-field magnet. Precession frequencies of individual protons are 
much more similar in the stray field as opposed to the high-field. Since isotropic mixing 
defines the transfer of PHIP-derived polarisation between protons as an exchange of 
energy between nuclear spins having different temperatures, conducting these 
experiments in the stray field is accordingly more efficient. The difference in efficiency 
is evident when spectra attained from both PASADENA and ALTADENA methods are 
compared. Enhancements could be somewhat increased if polarisation could be solely 
directed to protons, excluding heteronuclei. It can be said that high para-hydrogenation 
rates significantly increase transfer of PHIP to heteronuclei in both cases of PASADENA 
and ALTADENA.44  
 
1.3.7. SABRE (Signal amplification by reversible exchange) 
The more recent development of a non-intrusive PHIP technique has gained massive 
popularity in the polarisation community. Signal Amplification by Reversible Exchange 
transfers polarisation from p-H2 derived hydride ligands bound to a SABRE catalyst, to 
the protons of the hyperpolarisable substrate via the establishment of a J-coupling 
(scalar) network.42 A simple catalytic cycle for the process can be seen in Scheme 1 and 
in a review by Mewis.42 SABRE first appeared in the literature in 2009, when Duckett et 
al. indicated that PHIP was possible without hydrogenating an analyte.47 This offered a 
new alternative to conventional PHIP. There was now a method which hyperpolarised 
an analyte without chemically altering it. This in turn opened up a whole host of 
potential hyperpolarisable analytes, as the pre-requisite for a double/triple bond to 
necessitate hyperpolarisation transfer was no more. Though the process does require a 
carefully constructed metal-centred catalyst (normally Ir), experimental times can be 
27 
 
made strikingly short (~seconds) as catalyst activation can occur at ambient 
temperatures (catalyst decomposes upon heating) without the need of sophisticated 
equipment (as demonstrated in this work).48 There has been extensive development of 
SABRE catalysts in order to achieve the optimum ligand exchange rates. The exchange 
rates of substrate and hydrogen to and from the catalyst need to complement each 
other (in order for catalytic cycle to be maintained) to achieve optimal 
hyperpolarisation.42 Early work suggested phosphine ligands facilitated maximum 
hyperpolarisation, however upon analysis of different nitrogen N-heterocyclic carbenes 
(NHC), IMes (1,3-bis(2,4,6-trimethylphenyl)imidazole-2-ylidene) proved to be the most 
effective.49  
 
 
Scheme 1: Catalytic cycle for SABRE.42 
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2. Experimental Methodologies 
2.1. Reagents 
1-(4-pyridylmethyl)piperazine hydrochloride (4-PMP.3HCl) was prepared by treating a 
solution of 1-(4-pyridylmethyl)piperazine (0.5 g, 2.82 mmol) in diethyl ether (10 mL) with 
4M hydrogen chloride in dioxane (5.6 mL, 11.2 mmol, 4 eq.).  The crude product was 
purified by recrystallisation from acetone to give the target compound as a beige 
powder (0.81 g, 100%).  The compound was fully characterised by NMR, IR and MS 
before use. 2, 3 and 4-PMP freebase were purchased from Fluorochem Ltd. (Hadfield, 
UK) and were used without further purification.50 BZP.2HCl was purchased from Sigma-
Aldrich. Solvents (Sigma-Aldrich, Gillingham, UK and Fisher Scientific, Loughborough, 
UK) were used as received. A tablet of 4-PMP.3HCl (circa. 100 mg) was prepared using 
an adaptation of the procedure reported by Hamad et al.51 1-(cyclohexylmethyl)-1H-
indole-3-carboxylic acid 8-quinolinyl ester (BB-22) was obtained from BRC Fine 
Chemicals (London, UK; https://www.brc-finechemicals.com) and used without further 
purification.  The compound was fully characterised by NMR, IR and MS before use (see 
Appendix). 
 
2.2. Instrumentation 
High field 1H NMR and 13C NMR (10 mg of compound to be analysed/600 μL in CDOD3) 
spectra were acquired on a JEOL AS-400 (JEOL, Tokyo, Japan) NMR spectrometer 
operating at a 1H resonance frequency of 400 MHz and referenced to the residual 
solvent peak (δ = 3.33). Low field 1H NMR spectra were acquired on an Oxford 
Instruments bench-top Pulsar® NMR spectrometer operating at a 1H resonance 
frequency of 60 MHz and referenced to the residual solvent peak (δ = 3.33). GC-MS 
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analysis was performed using an Agilent 6850 GC and a MS5973 mass selective detector 
(Agilent Technologies, Wokingham, UK). The mass spectrometer was operated in the 
electron ionisation mode at 70 eV. Separation was achieved with a capillary column (HP5 
MS, 30 m Å∼ 0.25 mm i.d. 0.25 μm) with helium as the carrier gas at a constant flow 
rate of 1.0 mL min−1. The oven temperature programme started at 60 °C, increased at 
15 °C/min and was held at 300 °C for 3 minutes, unless stated otherwise. A 1-μL aliquot 
of the samples (qualitative analysis, calibration standards and test solutions) were 
injected (manually) with a split ratio of 20:1. The injector and the GC interface 
temperatures were both maintained at 280°C and 300°C respectively. The MS source 
and quadrupole temperatures were set at 230°C and 150°C, respectively. Mass spectra 
were obtained in full scan mode (50 – 550 amu). Calibration standards were made up as 
shown in table 1. Each calibration standard was injected six times. 
 
2.3. Generic Hyperpolarisation Sample Preparation and Method 
Five equivalents (eq) of substrate (relative to the catalyst), 2 mg [Ir(IMes)(COD)Cl] 
(catalyst) dissolved in 0.6 mL d4-methanol was added to a Young’s capped NMR tube. * 
1The sample was de-gassed three times using a freeze-thaw method that involved 
submerging the tube in an acetone/dry-ice slush bath and then removing the headspace 
using a Schlenk-line. The thermal (Boltzmann) one-scan spectrum was acquired using a 
low-field 60 MHz Oxford Instruments Pulsar® bench-top NMR spectrometer. 
Parahydrogen was introduced to the NMR tube at a pressure of 3.0 bar. The NMR tube 
                                                     
* Some samples also had Triethylamine (TEA) added to them either at the start, or sequentially throughout an 
experiment. 
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was shaken vigorously in the vertical plane (in Earth’s magnetic field (0.5 G)) for ten 
seconds, prior to being immediately transferred to the spectrometer to acquire the 1H 
NMR spectrum. The NMR tube was shaken and analysed three times for each addition 
of parahydrogen to the Young’s capped NMR tube. Details of the quantities used in each 
study are listed in Table 1. 
 
Table 1 - Quantities used in the SABRE studies throughout this project. 
 
 
2.3.1. Adaptations to the Generic Hyperpolarisation Method 
For the experiments in which TEA was added, the generic hyperpolarisation method was 
adapted. For the sequential addition of TEA to one sample, the sample was considered 
a new sample after each addition, and so the experimental method is then re-followed 
Study 
Number 
Compound Quantity 
of 
Compound 
Catalyst 
(mg) 
D4-Methanol 
(mL) 
TEA (eq) p-H2 
Pressure 
(bar) 
1 4-PMP (f) 2.76  μL 2 0.6 0 3.0 
2 4-PMP.3HCl 4.44 mg 2 0.6 1.2 3.0 
3 BZP.2HCl 3.87 mg 2 0.6 1.2 3.0 
4 4-PMP (f) 2.76  μL 2 0.6 1.2 3.0 
5 4-PMP (f) 2.76  μL 2 0.6 5.0 3.0 
6 4-PMP (f) 2.76  μL 2 0.6 10.0 3.0 
7 4-PMP (f) 2.76  μL 2 0.6 0.4 – 2.0 3.0 
8 4-PMP.3HCl 4.44 mg 2 0.6 1.2 3.0 
9 4-PMP.3HCl 4.44 mg 2 0.6 1.2 3.0 
10 4-PMP.3HCl 4.44 mg 2 0.6 0 – 10.0 3.0 
11 4-PMP (f) 2.76  μL 2 0.6 0 – 7.0 3.0 
12 4-PMP.3HCl 
Tablet 
2.00 mg 1 0.6 3.0 3.0 
13 BB-22 5.00 mg 2mg 0.6 0 3.0 
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from the point of de-gassing. It should also be noted that from study 10 onwards a new 
order of addition was followed that saw the reactants added in the following order: 
substrate, TEA, catalyst and solvent. 
 
Experiments 2 – 6, 8: TEA added to the other reagents at the start. Generic 
hyperpolarisation method followed. 
Experiment 7: 0.4 eq TEA added after each purge with parahydrogen. Generic 
hyperpolarisation method then followed from de-gassing. 
Experiment 9: TEA added directly to substrate before addition of catalyst and solvent. 
Generic hyperpolarisation method then followed.  
Experiment 10: TEA added directly to substrate (0, 1, 2, 3, 4, 5, 10 eq of TEA) before 
addition of catalyst. A different sample was used each time due to the requirement that 
TEA is added prior to solvent and catalyst. 
Experiment 11: TEA added directly to substrate (0, 1, 2, 7 eq of TEA) before addition of 
catalyst. A different sample was used each time due to the requirement that TEA is 
added prior to solvent and catalyst. 
Experiment 12: 30 mg of the tablet (6 mg active pharmaceutical ingredient) (API) was 
added to 900 μL d4-methnol before being filtered through a syringe filter. 300 μL of the 
resulting filtered solution (which contains only the API) was added to a vial prior to the 
addition of 3 eq TEA, 150 μL catalyst stock (6.66 mgmL-1) and 147 μL d4-methanol. The 
generic hyperpolarisation method then followed the de-gassing step. 
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Experiment 13: 1-(cyclohexylmethyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester (BB-
22). 100 eq Acetonitrile added in at the start. Generic hyperpolarisation method 
followed. 
 
2.4. Analysis 4-PMP.3HCl Tablet by GCMS  
2.4.1. Calibration Standards 
An eicosane stock solution (50 μg mL-1) was made by dissolving 5 mg eicosane in 50 mL 
methanol before performing a 1 in 2 dilution. The 4-PMP.3HCl stock solution (50 μg mL-
1 eicosane, 200 μg mL-1 4-PMP.3HCl) was made by dissolving 10 mg of the analyte in 50 
mL of the (50 ug mL-1) eicosane stock solution, to ensure the eicosane was at constant 
concentration. Aliquots of these two stock solutions were then mixed to give calibration 
standards containing 25, 50, 75, 100, 125 μg mL-1 of the analyte and 50 μg mL-1 eicosane.  
 
Table 2 - Information regarding the make-up of the calibration standards for GCMS. 
 
 
 
 
 
 
Calibration Standard 
(μg mL-1) 
[Eicosane] 
(μg mL-1) 
4-PMP.3HCl 
Stock (μL) 
Eicosane Stock 
(μL) 
50 50 200 600 
75 50 250 417 
100 50 500 500 
125 50 500 300 
150 50 600 200 
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2.4.2. Test Solution (Quantitative GC-MS Analysis) 
The tablet (502.2 mg) containing 100 mg active pharmaceutical ingredient (API), 4-
PMP.3HCl, was made in house via the use of KBr disk equipment. A test solution (100 μg 
mL-1) was made up by dissolving 5 mg of the tablet in 10 mL of an eicosane internal 
standard stock methanol solution (50 μg mL-1). The test samples were injected six times. 
 
2.4.3. Test Solution (Qualitative GC-MS Analysis) 
The tablet was weighed accurately prior to being homogenised via pestle and mortar. 
Testing solutions of each compound were made to the concentration 1 mg mL-1 (all 
samples spiked with eicosane, tablet testing solution 1 mg mL-1 API). The test samples 
were injected in duplicate. 
 
2.4.4. GC-MS Method Validation 
The GC-MS method was validated in accordance with The International Council for 
Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) 
guidelines using the following parameters: linearity, accuracy, precision, limit of 
detection (LOD) and limit of quantification (LOQ).12 Linearity, precision: six replicate 
injections of the calibration standards were performed and the data analysed under the 
same conditions. The %RSD was calculated for each replicate test sample. Accuracy 
(percentage recovery study): determined from spiked samples prepared in triplicate at 
three levels over a range of 80-120 % of the target concentration (100 μg mL-1). The 
percentage recovery and %RSD were calculated for each of the replicate samples. Limits 
of detection and quantification: six replicate injections of the calibration standards were 
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performed and the data analysed under the same conditions. The limits of detection and 
quantification were calculated based on the standard deviation of the response and the 
slope.52  
 
2.5. Standard Addition (SA) and Internal Standard (IS) Calibration 
2.5.1. Preparation from Stock Solutions  
For the SA two stock solutions were made up of known concentrations, one acting as 
the known and the other as the unknown. The two stocks were mixed so that the overall 
volume of each NMR tube was maintained at 600 μL, whilst the analyte concentration 
of the tubes increased. Table 3 details how this was completed. 
 
Table 3 - Information detailing the make-up of the SA calibration solutions. 
 
 
 
 
 
 
For IS, 5.52 μL 4-PMP was dissolved in 2 mL d4-methanol to give a stock solution (C) of 
concentration 2.76 μL mL -1. 1 μL Tetramethylsilane (TMS) was added to 0.5 mL d4-
methanol to give a TMS stock solution (D) of concentration 2 μL mL-1. The TMS 
Tube 
Number 
Stock A 
(Unknown) 
(μL) 
Stock B 
(Known) 
(μL) 
D4-Methanol 
(μL) 
Final 4-PMP 
concentration 
(μL mL-1) 
0 100 0 500 0.460 
1 100 100 400 1.293 
2 100 200 300 2.126 
3 100 300 200 2.960 
4 100 400 100 3.793 
35 
 
concentration was maintained at 0.33 μL mL-1 per calibration standard. Each tube was 
made up to 600 μL with d4-methanol. Table 4 details this. 
 
Table 4 - Information detailing the work up of IS calibrations standards. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tube 
Number 
Stock C 
(μL) 
Stock D 
(μL) 
D4-Methanol 
(μL) 
Final 4-PMP 
concentration 
 (μL mL-1) 
0 100 100 400 0.460 
1 200 100 300 0.920 
2 300 100 200 1.380 
3 400 100 100 1.840 
4 500 100 0 2.300 
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3. Hyperpolarisation of PMP Compounds 
3.1. Characterisation and Resolution via Bench-top NMR (BT-NMR) 
 
 
Figure 1: Low-field 1H NMR spectra for 2, 3 and 4-PMP (freebase). 
 
Individually the PMP isomers are easily characterised using 1H BT-NMR, high-field NMR 
and GC-MS (see Appendix). Each signal is resolved to the baseline and can be assigned 
to its corresponding hydrogen environment (NMR). On the contrary, compared to high-
field 1H NMR, the resolution suffers slightly with signals appearing broader and less 
sharp. However, bench-top NMR’s ease of use, time efficient procedures and portability 
mean that these drawbacks are easily mitigated. 1H NMR spectra were collected for all 
three isomers. All three have an identical aliphatic region and this is because the 
backbone of the compound (methyl piperazine) remains the same (Figure 1). However, 
the change in the position of the pyridyl group does cause some changes to the 
resonances observed in the aromatic region. Figure 1, which depicts the 1H NMR spectra 
for 2, 3 and 4-PMP (freebase) with all peaks assigned, shows these changes in resonance 
very clearly. Looking at 4-PMP, two doublets are observed at δ 8.25 and δ 7.25 which 
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correspond to the ortho- and meta-H nuclei respectively. Comparing this spectrum to 3-
PMP it is noticeable that there are now three signals present. This is a result of an 
increase in the number of 1H NMR environments present. The position of the pyridyl’s 
nitrogen causes the symmetry of the 1H NMR environments to be broken, causing two 
1H environments to become four. Similarly, in the 1H NMR spectrum of 2-PMP, there are 
now four individual environments leading to four individual resonances. This leads to 
the creation of what appears to be a multiplet at δ 7.25. The cause of this is simply down 
to the fact that a low-field 60 MHz BT-NMR was used. A weaker magnet naturally 
produces spectra that aren’t as resolved compared with high-field NMR instruments. 
However, the resonances were able to be assigned when the low-field spectrum was 
compared to a high-field spectrum. The problem arises when analysing a mixture of all 
three isomers via BT-NMR. Due to the characteristic resonances of all three isomers 
occurring between δ 6.8 and δ 8.5, it is impossible to differentiate between the three. 
The point here is that in the case of a street sample containing all three isomers, 
although this is highly unlikely, separating the three and characterising them would not 
be possible by using a standard 1H BT-NMR method.11 It would require the need for a 
more in-depth method to be employed, such as a 1H-1H COSY or GC-MS. Theresults of a 
GC-MS study to separate the three isomers is detailed in chapter 6.  
 
3.2. Hyperpolarisation of 4-PMP (freebase) 
The literature shows that SABRE hyperpolarisation is for the most part performed on 
nitrogen containing compounds.53-56 A very small part of the literature reports 
hyperpolarisation of nitrogen containing drug compounds.57, 58 Thus, PMP is of interest 
because of its potential ability to hyperpolarise well, but also because of its potential 
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future prevalence. To set a benchmark for the hyperpolarisation of the PMP family, 4-
PMP (freebase) was the first compound to undergo hyperpolarisation. With its moiety 
to bind to the catalyst being through the nitrogen situated in the four position of its 
pyridyl functionality, enhancement (ε) levels (enhancements were measured by 
normalising the integration of a characteristic hyperpolarised NMR signal, to its un-
hyperpolarised counter-part) were expected to be relatively high (ε ≈ 200). This was a 
prediction based on literature involving the hyperpolarisation of pyridine, taking into 
account non-optimal experimental conditions, which has been reported to show 
enhancements well over the 5000 – fold mark.49 Sterically speaking, the pyridyl nitrogen 
of 4-PMP (freebase) is not directly hindered, just like pyridine, and therefore should 
allow for most if not all the magnetization to be propagated from the parahydrogen 
derived hydride ligands through to the pyridyl protons. The piperazine nitrogen is ruled 
out as a potential ligation centre due to its protonation. It should be noted that 
polarisation via SABRE is not limited to protons; it has been reported that it can also be 
transferred to 13C and 15N.59 It is understood that the polarisation transfer through the 
nitrogen is allowed due to the existence of a free orbital on the atom, which reaches out 
into space close to the protons without posing a steric barrier for the temporary addition 
to the catalyst. This, and the fact that JHH-couplings are realistically limited to 5 bonds, 
explains why only the pyridyl protons become hyperpolarised.60 Excess substrate (5 
equivalents relative to the catalyst) was required in these studies in order to prevent 
side reactions (such as competition between solvent and substrate for the catalyst) 
during the activation of the catalyst. Failure to activate the catalyst effectively in the 
presence of sufficient substrate can lead to irreversible deactivation consistent with 
oligomerization of the catalyst molecules.61 A catalytic cycle for the SABRE process can 
be seen in Scheme 1. A 313-fold 1H NMR enhancement (Figure 2) was observed which 
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set a good benchmark for what could be expected from the PMP family. To contextualise 
this, 4-PMP freebase was hyperpolarised at low-field 0.5 G with 50% parahydrogen, 
whereas Chekmenev. et al. achieved ε ≈ 2,900 for pyridine at 9.4 T, using at least 65% 
parahydrogen.62 Considering 15% less para-hydrogen was used in tandem with a lower 
magnetic field (65 G has been shown to be optimal), where Boltzmann polarisation alone 
is one magnitude lower compared to at 9.4T, ε ≈ 300 is an impressive result.63 At first 
glance, it is clear to see the extent of the hyperpolarisation. Four hyperpolarised signals 
(2 emission; pointing down, and 2 absorption; pointing up) at δ 8.2, δ 8.0, δ 7.25 and δ 
6.75 are the direct result of a J-coupling (scalar) network established between the para-
hydrogen derived hydride ligands of [Ir(IMes)(4-PMP)3(H)2]+ and 4-PMP’s pyridyl 
group.42 The signals observed at δ 8.2 and δ 8.0 correspond to the ortho-hydrogen 
environment of both the dissociated (free) substrate and the bound substrate 
respectively. Because 4-PMP is hyperpolarised whilst bound to the catalyst, and since 
exchange of the substrate on and off the catalyst continues when the sample is analysed, 
the resulting NMR spectrum shows hyperpolarised signals of both dissociated and 
bound substrate. This information can give insight into the dissociative nature of the 
substrate in relation to the catalyst.48, 64 
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Figure 2: Hyperpolarised 1H NMR spectrum of 4-PMP (freebase). 
 
3.3. Freebasing 4-PMP.3HCl in-situ  
Being able to freebase a hydrochloride salt in-situ is vital in applying SABRE to drug 
analysis. It is very common for street drugs such as cocaine and ecstasy pills to have an 
API present in its hydrochloride salt. This is because it is very common for a nitrogen to 
become protonated and have a negatively charged counter ion. In order to 
hyperpolarise 4-PMP.3HCl, it was imperative that the salt was removed, as this would 
free up the pyridyl nitrogen to ligate to the SABRE catalyst. Attempting to hyperpolarise 
4-PMP.3HCl on its own resulted in no enhancement, as expected, as it has no ligation 
centre. In removing the HCl, the pyridyl’s nitrogen atom is freed up allowing for potential 
coordination to the catalyst during SABRE. The method adopted to freebase 4-PMP.3HCl 
(Scheme 2) utilises simple acid and base chemistry instead of freebasing via separation, 
which not only takes longer, but also cannot be done in-situ. The decision was made to 
ε ≈ 313 
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simply add TEA, a relatively strong base that is capable of removing the HCl from the 
compound, to the solution prior to hyperpolarisation. This decision was based on two 
different factors. Firstly, despite the fact performing a separation would be a chemist’s 
usual choice of method, in this instance it was not favourable. Using sodium bicarbonate 
and water to neutralise the compound before adding dichloromethane and separating 
would leave behind carbonic acid. Carbonic acid could potentially re-protonate PMP 
before it is recovered making it more difficult to recover from the aqueous layer. Both 
methods of freebasing leave behind unwanted impurities, however, freebasing with TEA 
minimises this. Therefore, and secondly, due to the only by-product being triethylamine 
hydrochloride (NEt3.HCl) which does not precipitate (this would affect the homogeneity 
of the solution and hence the quality of the 1H NMR spectrum), using TEA was justified. 
 
 Scheme 2: Reaction scheme for the freebasing of 4-PMP.3HCl with TEA. 
 
3.4. Hyperpolarisation of 4-PMP.3HCl 
Once the three equivalents of hydrogen chloride have been removed the compound is 
effectively in its freebased form (Scheme 2). This means that in theory, signal 
enhancements recorded should be directly comparable to 4-PMP (freebase). Figure 3 
shows the results of this experiment. Firstly, hyperpolarisation is evident and this is 
shown through the presence of enhanced absorption and emission signals at δ 8.2 and 
7.25 respectively. This observation alone confirms that the compound successfully 
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freebased to some extent, proving in-situ freebasing works. If the freebasing had been 
unsuccessful entirely there would be no observable hyperpolarisation. Assessing the 
hyperpolarisation gives an indication as to what degree the freebasing method worked. 
The ortho-hydrogen signal (δ 8.2) was chosen to calculate the enhancement, just like 
with 4-PMP (freebase). The result was ε ≈ 7.66 which is magnitudes lower when 
compared to the 300-fold enhancement that resulted from 4-PMP (freebase). It has 
been recognised, and acknowledged, that the reproducibility of SABRE when manually 
shaking the sample in the ‘stray field’ of the magnet is no better than 20% at best.56 
However, this enhancement falls outside the expected range of variance. This is 
evidence of some kind of unwanted reaction between the base and the catalyst, or the 
HCl salt has not been completely stripped from the compound. 
 
 
Figure 3: Hyperpolarised 1H NMR spectrum of 4-PMP.3HCl after the addition of 1.2eq triethylamine. 
ε ≈ 7.66 
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3.5. Does Triethylamine ‘Poison’ the Catalyst? 
The first investigation focused on the interaction of TEA with the catalyst. After seeing 
lower enhancements than were expected, it seemed plausible that TEA could in some 
way prevent the catalyst from activating. Since 4-PMP (freebase) hyperpolarised well, 
adding TEA to a solution containing 4-PMP (freebase) and measuring the resulting 
hyperpolarisation made logical sense in determining the chemical role of TEA. Figure 4 
shows that the signal enhancement for 4-PMP decreased by more than half from 313-
fold to 142-fold, suggesting the base has a negative impact on the reaction. Evidently, 
there is still a good level of hyperpolarisation despite triethylamine playing some role in 
reducing it. This investigation showed that TEA does not block the catalyst from 
activating, it simply decreases the amount of hyperpolarised substrate allowed to build 
up.  
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Figure 4:  Hyperpolarised 1H NMR Spectra of 4-PMP (freebase): A) No Triethylamine added, B) 1.2 eq 
Triethylamine added. 
 
3.6. Effect of Excess Triethylamine on Hyperpolarisation 
An experiment was conducted to investigate how excess TEA effects hyperpolarisation. 
5 eq of TEA was added, compared to 1.2 eq used in earlier experiments, to see if 
hyperpolarisation is prevented entirely at higher concentrations. In this instance, a 
sample of 4-PMP (freebase) was made up and hyperpolarised with one purge of para-
hydrogen to achieve a ‘baseline’ for signal enhancement. Only after this was TEA 
introduced to the sample. This was done so that it was clear to see the effect TEA had 
on enhancement levels. The 1H NMR spectra for the sample containing 5 eq of TEA are 
shown in Figure 5. (A) is the thermal proton background taken prior to SABRE. It is 
ε ≈ 313 
ε ≈ 161.0 
B 
A 
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notable that there is no TEA present due to the lack of a signal (triplet) at δ 0.9. Catalyst 
activation can be confirmed in (B) due to the signal enhancements and the presence of 
hydride signals at δ -12.5 and δ -17.5. Furthermore, spectra C – G show small signals at 
δ -23 which are further indication of a healthy catalyst.61 The pinnacle of 
hyperpolarisation is observed in (C) (ε ≈ 23.18) before it decreases in (D) (ε ≈ 8.6), due 
to the majority of para-hydrogen becoming ‘spent’ and converting back into ortho-
hydrogen. It is at this point the headspace of the NMR tube is removed making way for 
a fresh purge of para-hydrogen. 5 eq of TEA was added before the addition of more 
para-hydrogen and the collection of spectrum (E). Signal enhancement continues to 
decrease in (E) (ε ≈ 4.73) before ceasing completely in (F). This comes immediately after 
the addition of TEA. Thus, increasing the concentration of TEA in the sample so that it is 
in excess causes hyperpolarisation to stop completely. 
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Figure 5: 1H NMR SABRE spectra for addition of 5eq TEA to 4-PMP (freebase). (A) is the thermal 
spectrum, (B) was taken after the first para-hydrogen purge, (C) and (D) are the result of the 2nd and 
3rd tube shake from the 1st purge. (E), (F) and (G) correspond to the 1st, 2nd and 3rd tube shake after the 
introduction of the 2nd para-hydrogen purge. 
 
3.7. The Sequential Addition of Triethylamine 
Understanding that hyperpolarisation is supressed at 5 eq (vast excess), a study working 
upwards from 0.4 eq was conducted on 4-PMP (freebase) to examine how 
hyperpolarisation changes at different concentrations. Incrementally increasing the 
concentration of TEA and recording the resulting hyperpolarisation essentially allows 
the bigger picture to be observed. Since 0.4 eq (0.434 μL) is such a small amount, and 
bearing in mind TEA is volatile, it was vital to check the NMR spectra to confirm its 
addition had taken place. Figure 6 shows this distinctly. The resonance (triplet) at δ 0.9, 
which is caused by TEA, increases in size after each addition. Thus, it is possible to 
confirm to a high degree of certainty that TEA was successfully added. In terms of 
hyperpolarisation, the signal enhancements calculated at each concentration of TEA are 
shown graphically in Figure 7. Overall, there is a slight positive correlation which shows 
G
A 
F
A E
A D
A C 
B 
A 
47 
 
that TEA does aid hyperpolarisation. When focus is turned to equivalence (0 and 2 
specifically), signal enhancement doubles from a 20-fold enhancement to a 43-fold 
enhancement. On the contrary, there is a lot of variance in-between these results, 
especially in regard to the signal enhancement calculated at 0.8 eq TEA. This result 
stands out as an anomaly more than any other data point for the simple reason that 
upon its removal, there would be a constant steady increase in signal enhancement as 
TEA concentration increases. Furthermore, the large amount of variance cannot be 
ignored or overlooked. Even when removing this anomaly there is still too much 
variance. Although the R2 value would rise to 0.8388 from 0.6205, which is an 
improvement in linearity, there is too much variance to make meaningful conclusions. 
This experiment was deemed inconclusive, thus necessitating further investigations. 
 
 
Figure 6: Stacked 1H NMR spectra for the sequential addition of triethylamine to 4-PMP freebase. 
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Figure 7: Graph showing how increasing amounts of TEA effect the hyperpolarisation levels of 4-
PMP.3HCl 
 
It was now known that adding an excess of TEA to 4-PMP.3HCl has a detrimental effect 
whilst not adding enough makes hyperpolarisation unlikely to occur. Therefore, the 
medium in which optimal hyperpolarisation can be seen with 4-PMP.3HCl needed to be 
discovered. After observing the large amount of variance in Figure 7 it became apparent 
that the order of addition of TEA to the reaction could be crucial. Perhaps TEA interacted 
with the catalyst preferentially over 4-PMP. Up unto this point the substrate was added 
first followed by the catalyst, solvent and then TEA. It was decided that the base should 
be moved up the order of addition, adding it directly to the substrate to maximise their 
interaction. This way, TEA would interact solely with the substrate and strip it of its HCl 
salt prior to the addition of the catalyst. This step is key as it means upon the catalyst 
being activated, 4-PMP.3HCl will essentially be 4-PMP (freebase) which is already known 
to enhance well ( 
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Figure 2). The visible increase in enhancement at 0.8 eq of TEA is understood to be a 
result of the relatively large variance (20%) associated with the ‘shake and analyse’ 
technique.65  
3.8. Changing the Order of Addition 
To prove the importance of the order of addition, two experiments were conducted on 
4-PMP.3HCl (Experiment 8 and 9, Table 1). Experiment 8 utilised the order of addition 
that had been used up until now whereas experiment 9 followed a proposed ‘new order 
of addition’ (added in the order of substrate, base, catalyst, solvent). Both were 
hyperpolarised using SABRE and their signal enhancements recorded in order to deduce 
which order of addition produces better enhancements. Figure 8 shows the 
hyperpolarised 1H NMR spectra for experiments 8 and 9. The first thing that stands out 
from this data is how they look to be identical, but this is deceiving. The signal 
enhancement for experiment 8 was calculated to be 8-fold (ε ≈ 7.66) whereas a 13-fold 
(ε ≈ 12.87) enhancement was recorded for experiment 9. Despite the new order of 
addition giving an enhancement nearly two times that of the previous order of addition, 
the results are incredibly close to the 20% variance that is rife when using the ‘shake and 
analyse’ technique.65 These results weren’t as clear cut as they were expected to be, 
however, moving forward it made logical sense to follow the new order of addition. 
Adding TEA directly to the substrate allows for the formation of more 4-PMP (freebase) 
prior to the addition of the catalyst and solvent. This in turn reduces the chance of TEA 
interacting with the catalyst instead of the substrate, which prevents altering and/or 
blocking of the catalytic cycle. 
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Figure 8: 1H NMR spectra for experiments 8 and 9; determining how much the order of addition effects 
hyperpolarisation. Experiment 8 (Green), Experiment 9 (Maroon). 
 
3.9. The Sequential Addition of Triethylamine (4-PMP.3HCl) 
Moving forward, the next step was to determine the concentration of TEA at which 
maximum hyperpolarisation could be observed in 4-PMP.3HCl. This experiment involved 
adding TEA in to the sample sequentially whilst using the new order of addition. When 
TEA was added to the sample last, it was a simple procedure that allowed for the same 
sample to be analysed throughout the whole study. In order to add more TEA to the 
sample, the screw top of the Young’s NMR tube would be removed, the TEA added and 
the sample de-gassed. As TEA is now being introduced directly to the substrate before 
the addition of the catalyst, this is no longer achievable. There is now the requirement 
for a new sample to be made up for each TEA concentration tested. To do this 
appropriately, concentrations of substrate and catalyst had to be kept the same 
throughout the study, therefore stock solutions of substrate and catalyst were created. 
However, the solubility of 4-PMP.3HCl posed a problem when trying to achieve this. 4-
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PMP.3HCl has a solubility of 0.74 mg μL-1 in methanol-d4. To attain a substrate 
concentration of 4.44 mg in the NMR tube would require 600 μL of solvent, leaving no 
room for the catalyst stock (100 μL) and 0 - 22 μL (0 – 10 eq) of TEA. It was vital to 
maintain a total NMR tube volume of 600 μL as this is the volume used in every study in 
this project. The only way to solve this complication was to weigh out seven batches of 
4.44mg (4-PMP.3HCl), adding to each batch the TEA, 100 μL of catalyst stock (2 mg / 100 
μL) and solvent to reach a total tube volume of 600 μL. Details of the sample 
concentrations are shown in Table 5.  
 
Table 5 - Table showing NMR tube concentrations for sequential addition of TEA to 4-PMP.3HCl. Catalyst 
stock (2 mg / 100 μL). 
 
 
The enhancement data can be seen in Figure 9, which shows graphically how each 
addition of TEA affects the hyperpolarisation of 4-PMP.3HCl. When there are 0 eq of TEA 
in the sample, no hyperpolarisation is reported. This was carried out to reinforce that 
addition of TEA is necessary. Upon the addition of 1 eq TEA, hyperpolarisation begins to 
be evident. A 5-fold enhancement was recorded which signifies that the catalyst has 
 
Tube 
No. 
 
Vol Cat. 
Stock (μL) 
 
4-PMP.3HCl   
(mg) 
 
Vol. TEA   
(μL) 
 
Vol. MeOD   
(μL) 
 
TEA Eq. 
 
Total Vol. 
(μL) 
1 100 4.44 0 500 0 600 
2 100 4.44 2.18 497.82 1 600 
3 100 4.44 4.35 495.65 2 600 
4 100 4.44 6.53 493.47 3 600 
5 100 4.44 8.70 491.30 4 600 
6 100 4.44 10.90 489.10 5 600 
7 100 4.44 21.75 478.25 10 600 
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become activated, which in turn allows for the catalytic cycle to take place. In addition, 
this is a very similar result to the first attempt at hyperpolarising 4-PMP.HCl, meaning 
the 13-fold enhancement previously seen when testing the new order of addition has 
been verified as a trusted result. Moreover, at 2 eq TEA, a significant amount of 
hyperpolarised substrate can build up. At this concentration of TEA, a 193-fold increase 
in signal is observed. This is both interesting and significant as it is larger than the 
enhancement seen when TEA was added to 4-PMP freebase (161-fold). At 3 eq of TEA, 
the substrate is now theoretically 4-PMP (freebase) as all the HCl should have been 
removed, leaving NEt3.HCl in solution. At this TEA concentration the largest signal 
enhancement of 363-fold was observed. As predicted, this is directly comparable to the 
signal enhancement seen with 4-PMP (freebase) without TEA (313-fold). This confirms 
that at 3 eq TEA, 4-PMP.3HCl is completely converted to 4-PMP (freebase). In 
comparison to a study carried out on nicotinamide, where the hyperpolarisation was 
conducted at 6±4 mT and detected at 9.4 T (0.5 G and 1.4 T respectively in this work), 
the reported signal enhancement of the ortho-protons is 77.2-fold and 88.1-fold. At a 
lower magnetic field, with increased competition for the catalyst after freebasing and 
without bubbling of para-hydrogen through the sample, the 363-fold signal 
enhancement reported in this work is exceptional.61 In the same study, higher 
concentrations of catalyst and substrate also struggled to better the results done in this 
study. A SABRE experiment on pyridine using concentrations of 8 mM and 32 mM for 
catalyst and substrate respectively (5 mM and 25 mM in this study), achieved 
enhancements barely larger than that seen in the corresponding 1H NMR thermal 
spectrum (enhancement values were not reported, shown through NMR spectrum). This 
study was again carried out at high-field 9.4 T compared to 1.4 T in this work.61 
Furthermore, work done by P. Spannring et. al. only managed to achieve an 
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enhancement of ε ≈ 24 for free pyridine in D2O using a 300 mHz spectrometer, despite 
using 10 eq substrate relative to the catalyst. Their work utilised an IDEG SABRE catalyst 
as opposed to IMes in this study, however, this shows why IMes is generally the 
preferred SABRE catalyst.66 Interestingly, when 4 eq of TEA is added to the sample, 
hyperpolarisation levels begin to drop off, dipping to a 197-fold signal enhancement. 
This suggests that after 4-PMP.3HCl becomes 4-PMP (freebase) and an excess of TEA 
starts to build up, which inhibits the catalytic cycle in some way leading to a drop in the 
amount of hyperpolarised substrate present. Again, the addition of 5 eq of TEA sees 
hyperpolarisation decrease further. At this concentration, the enhancement observed 
was 85-fold. This is further confirmation that excess TEA is unfavourable when achieving 
optimal hyperpolarisation. Finally, the addition of 10 eq TEA to the sample sees the 
hyperpolarisation stay at a similar level, rising ever slightly to a 95-fold enhancement. It 
is fair to say that hyperpolarisation plateaus after the addition of 5 eq TEA due to the 
build-up of a huge excess of TEA.  
 
Figure 9: Graph showing how increasing the concentration of TEA effects the hyperpolarisation of 4-
PMP.3HCl. 
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Table 6 - How 4-PMP.3HCl and 4-PMP (freebase) were compared in terms of eq of TEA added. E.g. 3 eq 
TEA with 4-PMP.3HCl was compared to 0 eq TEA with 4-PMP (freebase). 
Compound Equivalence of TEA 
4-PMP.3HCl 3 4 5 10 
4-PMP 
(freebase) 
0 1 2 7 
 
 
3.10. The Sequential Addition of Triethylamine to 4-PMP (freebase)  
A lot was gained from the sequential addition of TEA to 4-PMP.3HCl. Firstly, using 3 eq 
of TEA provides the optimum level of hyperpolarisation. This is because 4-PMP.3HCl 
transforms to its freebase at 3 eq of TEA. Secondly, after 3 eq of TEA is added 
hyperpolarisation can be expected to decrease and eventually plateau at a significantly 
lower level. This is due to a vast excess of TEA building up and blocking access to the 
catalyst. A similar trend was expected in this study. When trying to uncover a 
hyperpolarisation correlation between TEA and PMP, it helps to consider 4-PMP.3HCl 
being in its freebased form in the presence of 3 eq of TEA. In addition, 4-PMP freebase 
is already in its freebased form at 0 eq of TEA. It is for this reason that during experiment 
11, the sequential addition of triethylamine to 4-PMP freebase, 3 eq TEA with 4-
PMP.3HCl was compared to 0eq TEA with 4-PMP freebase and so forth. This is better 
visualised in Table 6. Hyperpolarisation levels should be highest at 0 eq TEA before 
dropping off and plateauing. At a TEA concentration of 0, a 105-fold signal enhancement 
was recorded. This is 66% lower than what was observed with the previous order of 
addition, and 3 eq of TEA (4-PMP.3HCl) experiment. When 1 eq TEA was added, 
hyperpolarisation began to decrease following the trend set by 4-PMP.3HCl. A signal 
enhancement of 25 was observed which is one quarter the size of the signal seen with 
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4-PMP.3HCl. Despite being much lower than expected these results follow the expected 
trend. Moving forward, hyperpolarisation decreased even further when 2 and 5 eq of 
TEA were added to the sample. The signal enhancements reported here were 15-fold 
and 4-fold respectively. Despite the measurements of hyperpolarisation not matching 
up with 4-PMP-3HCl, the trend is obeyed completely. This can be seen in Figure 10. If 
Figure 9 is compared to Figure 10, the similarities are clear to see. Optimal 
hyperpolarisation occurs at 3 eq of TEA in both substrates before decreasing 
substantially and plateauing. Therefore, the same can be said for 4-PMP freebase that 
was said for its HCl salt. As there is no HCl to remove, the concentration of TEA builds 
up until it is in vast excess. In the process, it blocks and reduces the chance of any 
substrate-catalyst interaction, resulting in decreasing amounts of hyperpolarisation 
being observed. Excess TEA is detrimental to hyperpolarisation.  
 
 
Figure 10: Graph showing how increasing the concentration of TEA effects the hyperpolarisation of 4-
PMP (freebase). 
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3.11. 2-PMP and 3-PMP 
 
 
Figure 11: Structures for 3-pyridylmethylpiperazine (3-PMP) and 2-pyridylmethylpiperazine (2-PMP). 
 
3-PMP and 2-PMP, two isomers of 4-PMP, were also studied regarding their 
hyperpolarisability, characterisation and separation. The only difference between the 
isomers is the position of the pyridyl ring, this is shown in Figure 11. Each isomer was 
characterised successfully via both high and low-field BT-NMR. The one problem that 
was encountered arose when attempting to separate and characterise a mixture of all 
three isomers. This would have huge implications when trying to determine the 
concentration of a sample.67 In terms of quantification of a mixture, integrating the 
signals of the separate isomers cannot be achieved with 100% accuracy. Some 
resonances overlap meaning the true integral of a signal is problematic to determine. 
Moreover, as the position of the pyridyl changes from 3 to 2, steric hindrance acting on 
the nitrogen is increased. The cause of the steric hindrance is from the methylene 
connecting the pyridyl to the piperazine, and the piperazine functionality itself. Steric 
hindrance plays no role in the characterisation of these isomers but does come into play 
during hyperpolarisation. Literature reports the more sterically hindered a compounds 
moiety to bind to the catalyst is, the lower the resulting hyperpolarisation.62 With this 
in mind it was expected that hyperpolarisation would decrease the closer the nitrogen 
moves to the rest of the structure.  
3-PMP 2-PMP 
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3.11.1. Hyperpolarisation 
Taking into account what was reported by Chekmenev et. al. that steric hindrance alters 
the time scale of the SABRE exchange process, or reduces the association constant, it 
was expected that lower levels of hyperpolarisation would be observed in these 
isomers.62 As the pyridyl nitrogen moves closer to the methyl piperazine part of the 
compound, steric hindrance increases and alters its ability to bind to the SABRE catalyst, 
ultimately reducing the accessibility of N to the catalyst.62, 68, 69 The free orbital of the 
nitrogen is increasingly inhibited by the piperazine group in the 2- and 3-isomers, 
significantly reducing the amount of hyperpolarisable substrate allowed to build up due 
to being unable to efficiently ligate to the iridium centre. The enhancements confirmed 
overall the pattern Chekmenev reported.62 The hyperpolarisation of 3-PMP shows 
symptoms of steric hindrance effects with an 8-fold signal enhancement (ortho-
hydrogen signal) being observed. Compared to the 300-fold enhancement seen with 4-
PMP (least hindered) (Figure 2), this is a massive indication of how sensitive the SABRE 
process is in regard to a sterically hindered substrate. Furthermore, with 2-PMP, 
negligible increase in signal intensity is observed. The presence of an emission resonance 
exists, however it is negligible in size (see Figure 12). This study gives insight into the 
limits of SABRE substrates when using an IMes SABRE catalyst. It also paints a clear 
picture of how subtle changes to the structure of a substrate can have huge impacts on 
its hyperpolarisability. 
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Figure 12: Hyperpolarised 1H NMR spectra for 2-PMP. 
 
3.12. Summary 
TEA proved to be a good choice of base for the removal of the HCl from 4-PMP.3HCl. 
The discovery of the optimal [TEA] paved the way for some outstanding signal 
enhancements, the largest being a 363-fold enhancement which was observed after 
freebasing 4-PMP.3HCl with 3 eq of TEA (see Figure 10). It is now also apparent that 
adding less than 3 eq of TEA could cause disproportionate deprotonation, leading to a 
mixture of compounds present, potentially with different protonated/deprotonated 
sites. This could be the cause for the variance in results in Figure 7. Changing the order 
of addition was a logical move to make. Although experiments 8 and 9 showed that the 
new order of addition offers a slight advantage in terms of signal enhancement, the two 
results looked comparable. Moving forward, it made sense to follow the new order of 
addition. Despite the 20% variance associated with shaking and analysing, some great 
Signals due to hyperpolarisation 
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enhancements have been achieved in this work, 65  as well as the unearthing of a pattern 
for how TEA effects PMP hyperpolarisation. Of course, access to a polarisation system 
like the one reported by Duckett et. al, would be beneficial and would no doubt improve 
reproducibility.65 Working at higher magnetic fields and lower temperatures would also 
improve hyperpolarisation levels, however, the importance here is that it is shown to be 
possible to achieve strong hyperpolarisation at lower magnetic fields/temperatures. 
This makes way for the application of bench-top NMR hyperpolarisation to mobile drug 
analysis, detection and/or characterisation. The most explanatory reason for the 
decrease in hyperpolarisation at high [TEA] is down to base-catalyst interaction. As 
excess [TEA] builds up, the chance of interactions between itself and the catalyst 
increases. As TEA begins to interact more with the catalyst, it proceeds to prevent 4-
PMP doing so. Furthermore, it is thought that as TEA is less dissociative than 4-PMP (4-
PMP is a weakly interacting ligand), the catalytic cycle which relies on the non-hydride 
ligand dissociating, is no longer obeyed resulting in the impossibility of 
hyperpolarisation.70 This in turn explains why there is no evidence of hyperpolarised 
TEA. It is not impossible for 4-PMP to coordinate to the catalyst in these conditions 
resulting in some hyperpolarisation being seen, it just becomes less likely as [TEA] 
increases. The one thing that stands out more than anything else in this study is the 
signal enhancement for 4-PMP freebase observed during the sequential addition study. 
The same methodology was followed, this includes techniques and concentrations of 
reactants right down to using the same Gilson pipettes throughout. It is possible that 
different batches of catalyst (synthesised in house) perform slightly better or worse. 
However, the results are still remarkable. The hyperpolarisation of 2- and 3-PMP shows 
that steric hindrance plays a huge part in whether a substrate will hyperpolarise well or 
not. As shielding of the pyridyl increases, enhancement levels drop.  
60 
 
4. Hyperpolarisation of 4-PMP Tablet 
 
 
Figure 13: 4-PMP.3HCl Tablet. 
 
The culmination of this work brings together everything that was learned throughout 
the analysis of the PMP isomers and applies it to a potential ‘street sample’. By 
hyperpolarising a pill, it shows that hyperpolarisation can be applied to drug research, 
opening a whole new route of research for both hyperpolarisation and NPS. The 
extraction method developed allowed 4-PMP.3HCl to be freebased and isolated from 
the surrounding impurities before being successfully hyperpolarised. 
 
4.1. Adapting the Hyperpolarisation Method 
Hyperpolarising a street sample is not as straight forward as dissolving a small amount 
of it in the presence of the catalyst and some solvent, especially in the case of a pill. 
Since pills are solid, the API is going to be present in its hydrochloride salt form, meaning 
that potential ligand sites are protonated. Since this experiment was a ‘proof of concept’ 
it was already known that the API was in its HCl salt form and that the ligating pyridyl 
group was protonated. With this known, what was gathered from experiment 10 and 11 
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(the sequential addition of TEA to 4-PMP.3HCl and 4-PMP (freebase)) was put into action 
in this experiment (see details of experiment 12). Once the API was separated from the 
binding agents and fillers of the pill by syringe filtration, the general hyperpolarisation 
method could be followed.  
 
4.2. Results and discussion 
Figure 14 shows the thermal and hyperpolarised 1H NMR spectra of the 4-PMP.3HCl 
Tablet. The maroon spectrum (bottom) belongs to the thermal background taken prior 
to any hyperpolarisation of the sample. This spectrum had to be magnified by a 
magnitude of 32 to make it visible in the presence of the hyperpolarised spectrum (top). 
It is hard to make out the characteristic resonances of 4-PMP in the un-hyperpolarised 
spectrum, however, the hyperpolarised spectrum contains the correct peaks at 8.2 ppm 
to confirm firstly, that it is 4-PMP and secondly, that it has hyperpolarised. This proves 
the extraction method worked correctly. As expected, the ortho- and meta- hydrogen 
environments hyperpolarised well. In line with how all previous enhancements have 
been calculated, the ortho-H signal was analysed for its hyperpolarisation, recording a 
138-fold enhancement. This value follows the trend seen with the sequential additions, 
as ε ≈ 138 falls between the enhancements of 100 and 363 seen with 4-PMP (freebase) 
and 4-PMP.3HCl respectively, at [TEA] = 3 eq. The three eq of TEA used was based on 
the fact the pill contains 100 mg of 4-PMP.3HCl. The size of this enhancement was 
expected, based on the trends discovered earlier in this work. One fear was that a 
proportion of the API would not freebase and so would be collected in the filter, 
resulting in a lower enhancement being observed. This was not the case due to the 
extraction method performing correctly.  
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Figure 14: Hyperpolarised 1H NMR spectrum (turquoise) and 1H NMR thermal background spectrum 
(maroon) of 4-PMP.3HCl pill. The thermal spectrum is shown at x32 vertical magnification.  
 
 
 
X 32 
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Figure 15: Hydride region taken from the hyperpolarised spectra of the 4-PMP.3HCl based pill. Bottom 
to top: Thermal background, 1st para-hydrogen purge A, 1st para-hydrogen purge B, 2nd para-hydrogen 
purge A, 2nd para-hydrogen purge B, 3rd para-hydrogen purge. (A = first shake, B = second shake). 
 
A good indicator of successful catalyst activity is the appearance of the hydride region. 
After the first purge of para-hydrogen there should be two hydride resonances present. 
After further purges with para-hydrogen, there should be one characteristic resonance 
at -23 ppm which is in line with other experiments conducted. Figure 15 shows the 
hydride region for the hyperpolarised spectra of the 4-PMP.3HCl based pill. Firstly, the 
two resonances at -12.5 and -17.5 ppm result from the COD component undergoing 
hydrogenation. Once hydrogenated, the catalyst is fully activated and ready to 
propagate hyperpolarisation efficiently to the substrate. The addition of para-hydrogen 
to the complex means that Ir(I) is now Ir(III) which coincides with a change in geometry 
from square planar to octahedral. Furthermore, the consistent resonance at -23 ppm 
thereafter is confirmation of a single catalytic species in solution and that a methanol 
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adduct, as described elsewhere, is not observed.49, 61 This experiment worked with great 
success as the API hyperpolarised as expected. A 138-fold enhancement after extraction 
from a pill whilst using the ‘shake and analyse’ technique is remarkable, especially when 
compared to the hyperpolarisation of nicotinamide, which shows 77- to 300-fold 
enhancements, the latter of which was observed using a unique flow-system.56, 65, 66 The 
extraction method was key to achieving such a high enhancement in this experiment, 
without it the API simply would not hyperpolarise. Working with knowledge of the 
optimum TEA concentration required to freebase 4-PMP.3HCl meant that the salt could 
be freebased and isolated from the insoluble binding/filling agents of the pill, prior to 
filtration. This meant that upon filtration, most if not all the freebased API passed 
through the filter, leaving the impurities behind. It is fair to say the extraction method 
works well, presented no problems and is simple enough that it could be taken and 
applied in real world situations. One other important aspect in this study is the fact that 
only 2 mg of the API was used. This highlights the employment of SABRE to detect 
molecules at low concentration, as exemplified elsewhere and again backs up how 
efficient the extraction method was.54, 62, 71 2 mg is such a small amount that any loss of 
analyte in the filter would have resulted in a poor enhancement value. Furthermore, to 
obtain a creditable 1H NMR spectrum, around 10 mg of analyte and multiple scans are 
needed. This experiment produced far larger signals with a far smaller amount of analyte 
and in a single scan. What sets this work apart from some literature is its novel 
application to the real world. The aim is not to prove something is hyperpolarisable, it is 
to prove that a hyperpolarisation technique, SABRE, can be used for the benefit of the 
many. Some drugs do hyperpolarise. The literature is rife with the hyperpolarisation 
biologically relevant compounds used to treat diseases, such as tuberculosis and 
cancer.57, 65, 72 A report by P. Rayner et al. goes a step further by hyperpolarising the 
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crucial building blocks of some medicinal compounds; pyridazine, pyrimidine, pyrazine 
and isonicotinamide.58 In addition, investigations have also taken place into the 
behaviour of drug compounds in the SABRE catalytic cycle, in particular, how they 
exchange with iridium complexes.73 There have been some great advances in SABRE 
applications, particularly in the field of Magnetic Resonance Imaging (MRI), which 
suffers from the same sensitivity issues as NMR.43, 53, 74 Finding a need for 
hyperpolarisation is niche, and that is what this work does, by going a step further than 
addressing the inherent lack of sensitivity in NMR, which has been addressed greatly by 
L. S. Lloyd et al.71 It has been demonstrated here that it is possible to extract a NPS from 
a common formulation and then hyperpolarise it. The SABRE aspect of this process 
reduces the time taken to acquire spectra, the extraction process removes unwanted 
impurities that might otherwise cause resonance overlapping in the spectra, all the 
while the compound of interest is more importantly isolated for SABRE analysis. This 
opens up a whole host of possibilities for drug analysis, for example, developing further 
detection and extraction methods from more complex mixtures at low concentrations 
that would otherwise be un-detectable. 
 
4.3. Summary 
The experiment was successful in that the 4-PMP contained within the pill was 
successfully extracted and polarised by SABRE. Ultimately, this procedure could be 
applied to real world situations. The fact that the 138-fold enhancement is in line with 
all previous work done in this project backs up the legitimacy of the trends found. This 
is important due to the 20% variance threshold, that comes with the shake and analyse 
technique, which casts a small shadow of uncertainty.56, 65 Not only does this bring drug 
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analysis closer together with hyperpolarisation, it proves the two can work well with 
each other. It also offers major benefits to the analytical side of drug analysis due to the 
small amount of analyte required and the reduced time it takes to gather the data. This 
work goes beyond providing a solution to the notorious sensitivity issues associated with 
NMR, providing SABRE with another real world purpose. 
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5. Standard Addition (SA) and Internal Standard (IS) – Quantitative NMR 
(QNMR) 
 
Quantification in NMR is usually achieved using a referencing standard to calibrate the 
intensity scale of the measurement to a high degree of accuracy.75, 76 Method 
development in this area could also form part of the solution to the innate challenge 
within NMR spectroscopy, achieving absolute quantification of a chemical compound.75 
Optimising this quantification method for use on the bench-top NMR works toward 
achieving this and will provide a simple, cheaper and more portable solution to drug 
detection and quantification. In this project, it was useful to utilise both techniques and 
show that they can both be performed successfully via bench-top NMR, as they both 
have their advantages and disadvantages. SA is only possible when the concentration of 
an analyte is known, whereas the IS method does not have this requirement. Although, 
in the case that SA can be performed, it is slightly more time efficient compared to IS. 
 
5.1. Standard Addition 
The method of SA is a relatively simple, quantitative approach for calculating the 
concentration of an unknown sample, which has been shown to improve results when 
experiments were redesigned from simple calibration plots.77 It is carried out by 
analysing samples prepared from two stock solutions; one of a known concentration and 
another (the analyte under investigation) of an unknown concentration.78 The 
concentration of the unknown sample is calculated by either extrapolating the trend line 
of the plotted data back to the X-axis, or algebraically by re-arranging the equation of 
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the trend line (y = mx + c) to calculate x.79 When the x-axis is labelled ‘concentration of 
known stock added’, the calculated x-intercept reflects the concentration of the 
unknown that is present in the sample.80 Due to the time consuming manner of sample 
preparation, sample analysis and data interpretation, this method is best suited for 
studies involving a small number of samples, hence its employment in this study. 
However, SA has the potential to be extremely accurate due to the target analyte 
behaving as its own reference.79  
 
5.1.1. Proof of Concept 
In an attempt to prove that this method was applicable to this study, the concentration 
of the analyte that would otherwise be unknown in this instance, was known. Thus, 
when extrapolating the line of best-fit back to the x-axis to determine the unknown 
concentration, the value observed should correlate with the known unknown. This 
allows the accuracy of this method to be determined. 
 
5.2. Calibration (TMS Internal Standard)  
An IS of TMS was used as the reference in a separate calibration experiment. In this case, 
the response of the analyte is normalised to the response of the IS and plotted as a 
function of the analyte standard concentration. This is arguably more accurate than SA 
as the concentration of the IS is the same throughout the study.78, 81 Furthermore, this 
method is often argued to be a better choice for calibration due to strict SA 
requirements relating to the precision of a method.82 Quantification of street samples 
was not carried out. 
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5.3. Results and Discussion 
 
 
Figure 16: Standard addition calibration graph for 4-PMP (freebase). 
 
 
 
Figure 17: Standard addition calibration graph for 3-PMP (freebase). 
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Figure 18: Standard addition calibration graph for 2-PMP (freebase). 
 
 
Figure 19: Internal standard (TMS) calibration graph for 4-PMP (freebase). 
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amount of variance seen in the results of this experiment. This led to further samples 
being prepared from stock solutions. The results, shown in Table 7, show an acceptable 
accuracy. The concentration of tube 0 was already known to be 0.46 μL mL-1 (as this is a 
proof of concept), therefore this was the expected value for x. In regard to 4-PMP (Figure 
16), this technique was 100% accurate the second time round (three repetitions in total) 
with an average concentration of 0.47 μL mL-1. A standard deviation (SD) of s = 0.057 
and an average R2 value of 0.993 show how close the data points are when related to 
the mean. The range in the determined concentration was 0.11 μL mL-1. For 3-PMP 
(Figure 17), 100% accuracy was achieved on the first repetition whilst the average 
concentration (0.37 μL mL-1) was out by 0.11 μL mL-1. However, this experiment reports 
the largest range of results (0.14 μLmL-1). A SD of s = 0.08 was calculated which reflects 
this. 2-PMP (Figure 18) was accurate to within 0.8 μL mL-1 whilst showing a more concise 
range of results (0.04 μL mL-1). This precision is shown through the SD (0.02). The average 
2-PMP concentration determined was 0.51 μL mL-1. In regards to the IS method, a clear 
linear positive correlation can be seen (Figure 19). This shows that 60 MHz BT-NMR can 
offer top class precision and accuracy with more than one technique.  
 
Table 7 - Standard addition results. 
Analyte Average 
Concentration 
(μLmL-1) 
Range 
(μLmL-1) 
Standard Deviation 
4-PMP 0.47 0.11 0.057 
3-PMP 0.37 0.14 0.080 
2-PMP 0.51 0.04 0.020 
 
72 
 
5.4. Summary 
SA used in tandem with 60 MHz NMR was very accurate, determining concentrations 
within 0.01 μL (2%) of the true concentration with 4-PMP. This shows the strong 
potential for SA methods when quantifying with a bench-top NMR spectrometer. SA 
would be a great choice in method if/when using bench top NMR to quantify out in the 
field when the quantity of samples is small. The linearity of the IS method also proves 
that bench-top NMR can perform to a very high standard using more than one 
technique. Comparing the two methods, SA would have to be run for each unknown 
sample in order to determine their concentration, whereas with an IS, once the 
calibration is completed, each unknown sample concentration can be found with one 
run.  
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6. GC-MS Analysis 
6.1. Characterisation and Separation of PMP Isomers 
Gas chromatography mass spectroscopy (GCMS) was utilised to characterise and 
separate a mixture of the PMP isomers. Despite its unlikelihood in a street sample, the 
ability to separate a mixture of all three PMP isomers was vital for proof of concept. 
GCMS is the instrument of choice among scientists when a separation of similar 
compounds is required and thus was chosen for this work due to its high precision, 
accuracy and above all else, power. With the PMP isomers all having very similar 
structures and the same molecular weights (not including 4-PMP.3HCl) , this technique 
was the only valid option. It was possible after extensive method development to 
successfully characterise a mixture of all three isomers. 2-PMP eluted first (17.6 
minutes), with 3 and 4-PMP co-eluting shortly after (21.9 and 22.0 minutes respectively). 
Despite the co-elution, it is easy to visually determine which peak is which (Figure 20). 
It terms of method development, altering the ramping of the oven temperature played 
a crucial role in separating 3- and 4-PMP as much as possible. Changing this ramp so that 
the oven temperature increased at a slower rate meant that the two isomers would 
separate enough to be distinguishable. The starting temperature was maintained at 100 
°C for 50 minutes before ramping up at 30 °C/min until 310 °C was reached. This 
temperature was then held for 3 minutes.  
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Figure 20: GC-MS chromatograph for the separation of 2-, 3- and 4-PMP. 
 
 
6.2. Validation and the Quantification of a PMP Tablet 
As an extension to the hyperpolarisation of the 4-PMP.3HCl tablet, GC-MS was 
employed to provide a validated qualitative and quantitative method for the API of the 
tablet.83 The binding and filling agents present in the tablet formulation were removed 
prior to analysis via an extensively developed extraction method. The method 
development focused on testing the mixing times of the tablet when dissolved in a 
methanol-eicosane solution. The samples were made up the same, only the length of 
time they were placed in to the ultrasonic bath was varied. Sonication times of 1 min, 5 
mins, 10 mins, 15 mins, 20 mins, 25 mins, 30 mins and 50 mins were examined. 
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6.3. Results and discussion 
The method used to prepare the sample for GC-MS analysis was extremely simple. It 
required only that the analyte be dissolved in a methanol-eicosane solution before 
sonication and syringe filtration to dissolve the API and remove the adulterants 
respectively. In terms of the validation, the calibration standards demonstrated an 
acceptable correlation coefficient (r2 = 0.995) over an appropriate concentration range 
of 50.0 – 150.0 μg mL-1 with sufficient repeatability (RSD = 4.81–10.37%, n = 5). The Limit 
of Detection (LoD) and Limit of Quantification (LoQ) for the analyte were 15.64 and 
47.38 μg mL-1 respectively. The RSD for the tablet analysis was calculated to be 4.13% 
and the averaged integrated area ratio fitted onto the calibration graph. The two 
calibration graphs in Figure 21 and Figure 22 take into account all the Integrated Area 
Ratio(s) (IAR) at each concentration, and the average IAR at each concentration 
respectively.  
 
 
Figure 21: GC-MS calibration graph of average Integrated Area Ratio (IAR) for each concentration. 
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Figure 22: GC-MS calibration for all IAR points at each concentration. 
 
The correlation coefficients of both graphs in Figure 21 and Figure 22 are acceptable and 
therefore either could be used to quantify. Since the tablet was made to prove a 
concept, the concentration of the API was known to be ~ 100 mg. When quantifying the 
tablet by GC-MS, a concentration of this amount was expected. However, the 
concentration of the API in the tablet was calculated to be 72 mg, somewhat lower than 
the expected 100 mg. The validation was carried out using 4-PMP.3HCl, the API, with no 
issues whatsoever resulting in chromatographs that were clear, resolved to the baseline 
and provided great validation data (Figure 23). This provided reason to investigate the 
extraction process with the results of this shown in Figure 24.  
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Figure 23: 150 ugml-1 GCMS calibration chromatograph (4-PMP.3HCl). 
 
 
 
Figure 24: Graph showing how increasing sample mixing time effects its Integrated Area Ratio (IAR). 
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There is no correlation or linearity in Figure 24, thus showing that longer mixing times 
are not key in extracting the full amount of API. The potential for losing some analyte in 
the filter is present. In addition to this, as the tablet was made in-house there is the 
possibility that some of the API did not make it into the pill press. This would amount to 
a small proportion of the API not making it into the analysis sample. However, it is 
unlikely that so much would be lost due to this. This probed thoughts into another 
potential factor that could be restricting the amount of API extracted, polarity. Since 
methanol is moderately polar and the polarity of 4-PMP is unknown, it could be a 
possibility that 4-PMP (HCl) is a lot less polar than methanol or not polar at all and thus 
has reduced solubility in methanol. This question was raised earlier in this thesis 
resulting in a solubility test taking place. This test proved that 4-PMP.3HCl’s solubility 
limit is 7.2 mg mL-1, suggesting that there should be no solubility issues in this 
experiment. To completely rule out polarity being an issue, this experiment would need 
to be re-run in a range of solvents. 
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Figure 25: GC-MS chromatograph for the tablet analysis. 
 
6.4. Summary 
The calibration standards performed correctly and led to a successful validation, which 
shows that this method has a lot of potential going forward. However, to successfully 
quantify the tablet, the extraction issues need to be addressed. Increasing the time in 
which the sample was sonicated for made no real difference to the result. In saying this, 
determining how polar the analyte is would also be extremely helpful. Furthermore, 
looking into other types of extraction methods could also be favourable. A common 
extraction method used for GC-MS is solid-phase micro extraction (SPME) which can 
completely remove the need for a solvent.84 
 
7. Hyperpolarisation of 1-(cyclohexylmethyl)-1H-indole-3-carboxylic acid 8-
quinolinyl ester (BB-22) 
Hyperpolarisation studies into BB-22 were undertaken to expand this work to another 
prevalent group of NPS, synthetic cannabinoids.7 BB-22 was chosen because it offered a 
route into another group of NPS whilst creating another challenge in hyperpolarising 
such a bulky compound. The application of SABRE to bulkier and more sterically 
hindered compounds would be a breakthrough, as at the minute steric hindrance 
massively debilitates SABRE enhancements. 
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7.1. Results and Discussion 
Resonances at δ -13, -17 and -22 are indicative of the oxidative addition of parahydrogen 
to the catalyst, [Ir(IMes)(COD)Cl] (Figure 26). In addition to this the sample turned from 
dark yellow to light yellow in colour as a result of a change in oxidation state of the Ir 
centre, which Is further evidence of this addition. In terms of hyperpolarisation, the 
observation of multiple hydride resonances suggests the formation of a number of 
complexes. Furthermore, the presence of an emission resonance at 8 ppm is exemplary 
of some minor hyperpolarisation, although the enhancement is less than unity. 2-PMP 
behaved very similarly (Section 3.11.1).  
 
Figure 26: Low-field NMR spectrum for attempted hyperpolarisation of BB-22. 
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7.2. Summary 
The potential to hyperpolarise big compounds such as BB-22 is there, just right now it is 
difficult to find the optimum parameters. A breakthrough in this area would open up a 
whole host of compounds to hyperpolarisation that were previously 
unhyperpolarisable.  
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8. Conclusion 
To conclude, this work shows that it is possible to extract a compound of interest (NPS) 
from a common formulation (tablet) and subsequently hyperpolarise it. When the three 
freebased isomers were mixed together and analysed by NMR, it proved impossible to 
resolve the three. In light of this, all three were visually characterised by GC-MS as a 
mixture. This was made possible by firstly investigating the extent to which a group of 
piperazine isomers (2-, 3-, 4-PMP and 4-PMP.3HCl) hyperpolarise. As expected 4-PMP 
produced the largest enhancement (ε ≈ 300). This is because of the decreased steric 
crowding compared to 2- and 3-PMP. In terms of hyperpolarisation, determining the 
optimum concentration of TEA was crucial in the development of an extraction method. 
TEA proved to be a good choice of base with enhancements as large as ε ≈ 363 being 
observed (4-PMP.3HCl, 3 eq TEA). No other bases were investigated. It was found that a 
lower than optimum TEA concentration results in lower enhancement levels, thought to 
be the result of disproportionate deprotonation of the protonated nitrogen’s. Excess 
TEA also resulted in lower enhancements. This is understood to be because TEA can 
compete with 4-PMP for binding sites on the catalyst. The ‘shake and analyse’ technique 
used through this work casted a shadow of doubt over results early on, due to the 
potential 20% variance that comes with it.65 However, three eq of TEA relative to 4-
PMP.3HCl was proven to be the ideal concentration to convert 4-PMP.3HCl to 4-PMP 
freebase. Upon evaluation of the literature, this work would have no doubt benefitted 
from a system similar to that used by S. B. Duckett et al., demonstrated in their work.65 
The hyperpolarisation of the 4-PMP tablet really epitomises the work done as a whole 
in this study. The 138-fold enhancement observed when 4-PMP was isolated from the 
tablet and swiftly hyperpolarised, is a direct result of a simple but effective extraction 
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process. This also makes the method easily applicable to real world situations. 
Furthermore, since low substrate concentrations are permitted (as SABRE boosts 
detection limits of low-level analytes), sample preparation is relatively simple and data 
acquisition is very quick, making the novelty of this approach comprehensible. 
Moreover, in the grand scheme of SABRE hyperpolarisation, this research goes a step 
further than simply hyperpolarising compounds. It provides a niche application to an 
ever-evolving research area, NPS, opening the door for further development. The tablet 
was also analysed by GC-MS in an attempt to quantify. The linearity shown in Figure 21 
and Figure 22 are acceptable, however, API extraction issues meant the concentration 
calculated was 28 mg lower than expected. Some loss of API is expected due to 
human/systematic error during weighing, tablet pressing and filtration, however this is 
too large a loss for any or all of those factors to be the cause. Increasing the time that 
the sample was subjected to ultrasonication made no difference, leading to the belief 
that polarity may be the concern since methanol is moderately polar and the polarity of 
4-PMP is unknown. This would cause a reduction in the amount of dissolved analyte. 
The SA quantification method provided a strong level of accuracy (accurate to within 2% 
with 4-PMP), giving the technique strong potential as a method of choice, particularly 
due to its suitability to small sample sizes. The method of IS also provided acceptable 
linearity and is more favourable to large sample sizes whilst eliminating SA’s 
requirement for an analyte stock.  
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9. Future Work 
It would be great to continue this work to understand in more detail how the protonated 
nitrogen atoms of the NPS are deprotonated with TEA. This could be done by 
investigating NPS in their HCl salt form, which contain both more and less nitrogen’s. 
One experiment that is of particular interest would be to slightly alter what was done in 
this work, to see if the observed results were similar. It would involve adding HCl to a 
freebased PMP isomer, essentially changing it to its HCl form, before analysing it like 
seen in this work. In this instance, the product may contain a mixture of freebased and 
HCl salt isomers and it would be interesting to see how such a mixture would react to 
the addition of TEA prior to hyperpolarisation. Another route for future work would be 
to analyse a wider range of NPS. This would help to build a bigger picture around 
freebasing and hyperpolarising NPS. The question ‘would the same trends seen in this 
work carry through to other drug compounds?’ is one that if answered, would further 
the research conducted herein. Furthermore, seeing this work applied to an established 
drug analysis group is also possible. Due to the relative simplicity of the extraction and 
analysis method, it isn’t so farfetched that it couldn’t be situated in police stations or at 
borders. Finally, in terms of hyperpolarisation, it would be truly fantastic to broaden the 
horizons of the topic and try to ‘rock the apple cart’ in terms of hyperpolarisation limits. 
Working with bigger and bulkier compounds to see if they are hyperpolarisable is a very 
feasible route of research and would open a whole host of avenues for hyperpolarisation 
to combine with.  
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10. Appendix 
10.1. Characterisation Data for 2-PMP 
 
Figure 27: IR Spectrum for 2-PMP. 
 
 
 
Figure 28: High-field 1H NMR spectrum for 2-PMP. 
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Figure 29: High-field NMR 1H-1H COSY for 2-PMP. 
 
 
 
Figure 30: High-field DEPT NM for 2-PMP. 
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Figure 31: High-field 13C NMR for 2-PMP. 
 
 
Figure 32 LC-MS spectrum for 2-PMP. 
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10.2. Characterisation Data for 3-PMP 
 
Figure 33: IR spectrum for 3-PMP. 
 
 
Figure 34: High-field 1H NMR spectrum for 3-PMP. 
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Figure 35: High-field 1H-1H COSY NMR for 3-PMP. 
 
 
Figure 36: High-field DEPT NMR for 3-PMP. 
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Figure 37: High-field 13C NMR. 
 
 
 
Figure 38: LC-MS spectrum for 3-PMP. 
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10.3. Characterisation Data for 4-PMP 
 
Figure 39: High-field 1H NMR spectrum for 4-PMP. 
 
 
Figure 40: High-field 1H-1H COSY spectrum for 4-PMP. 
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Figure 41: High-field DEPT NMR for 4-PMP. 
 
 
Figure 42: High-field 13C NMR for 4-PMP. 
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Figure 43: LC-MS spectrum for 4-PMP. 
 
 
10.4. Characterisation Data for 4-PMP.3HCl 
 
 
Figure 44: IR spectrum for 4-PMP.3HCl. 
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Figure 45: LC-MS spectrum for 4-PMP.3HCl. 
 
 
10.5. Characterisation Data for 4-PMP.3HCl Tablet 
 
Figure 46: LC-MS spectrum for 4-PMP.3HCl tablet. 
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Figure 47: GC-MS for 4-PMP.3HCl tablet. 
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10.6. Characterisation Data for BB-22 
 
Figure 48: IR spectrum for BB-22. 
 
 
Figure 49: High-field 1H NMR spectrum for BB-22. 
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Figure 50: High-field 1H-1H COSY NMR spectrum for BB-22. 
 
 
 
 
Figure 51: High-field HMQC NMR spectrum for BB-22. 
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Figure 52: High-field 13C NMR spectrum for BB-22. 
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